$heff's $tation of $tocks & $olid DD

[Shizane]

$CMRX...$CERS...Not sure if it has been discussed on this board, but Chimerix Inc. and Cerus Corp. were mentioned in an article on CNBC.com on November 18th, 2014.

Note: I do own $CERS.

Study will test survivors' blood to treat Ebola

There are no drugs or vaccines approved now for Ebola, which has killed more than 5,000 people this year in West Africa, most of them in Guinea, Liberia and Sierra Leone. Doctors Without Borders last week also said it would host studies of experimental treatments and plasma at three of its West Africa treatment centers.

The drugs to be tested by both groups include brincidofovir, an antiviral medicine that has been tried in a few Ebola cases so far. Its maker, North Carolina-based Chimerix Inc., developed it to treat other types of viruses and lab tests suggest it might help fight Ebola.

One of the first patients successfully treated for Ebola in the U.S. — aid worker Dr. Kent Brantly — received plasma from a 14-year-old boy he treated in Africa, where he was infected. Brantly has donated plasma several times to Ebola patients in the U.S.

A plasma recipient must have a compatible blood type with the donor. Survivors who give plasma also must be tested to make sure they are cured of Ebola and don't have other diseases such as hepatitis, syphilis or HIV. The Africa study will take an added step — use of an experimental system by Cerus Corp. for inactivating viruses in blood.

Another Read found on the bottom of the WebPage is...

Position Paper on Collection and Use of Convalescent Plasma or Serum as an Element in Filovirus Outbreak Response

It talks about how the Blood Regulators Network (BRN) feels about plasma as a treatment in an outbreak.


Cerus is expected to announce the reply for the IDE for INTERCEPT any day now.